Erytech Pharma S.A. Banner Image

Erytech Pharma S.A.

  • Ticker ERYP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Erytech Pharma S.A. Logo Image
  • 201-500 Employees
  • Based in Lyon, France
ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS® platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs. ERYTECH’sMore primary focus is on the development of product candidates that target the altered metabolism of cancer cells by depriving them of amino acids necessary for their growth and survival.
4.8 / 5.0 (131)

Erytech Pharma S.A. reports have an aggregate usefulness score of 4.8 based on 131 reviews.

Erytech Pharma S.A.

Most Recent Annual Report

Erytech Pharma S.A.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Erytech Pharma S.A. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!